Archer Materials Limited · ASX:AXE

Archer Materials — Shareholder Meeting (November 2025)

18 slides from Archer Materials's shareholder meeting presentation, Nov 20, 2025

  1. Slide 1: Annual General Meeting - Presentation (ASX Announcement)

    Archer Materials Archer Materials Limited (ACN: 123 993 233) AGM Lot Fourteen, Frome Road, Adelaide SA 5000 www.archerx.com.au ASX Announcement (ASX: AXE) 20 November 2025 Annual General Meeting - Presentation Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to enclose a cop

  2. Slide 2: Annual General Meeting 2025

    For personal use only Annual General Meeting 2025 20 November 2025

  3. Slide 3: Overview

    For personal use only Overview 01

  4. Slide 4: About Archer: Our Technology

    ABOUT ARCHER Our Technology Archer Materials is the only ASX-listed quantum technologies company. We are developing products to address high-value problems in computing, sensing, and medical markets. For personal use only 12CQ Chip A carbon-based Qubit demo quantum 1HCY26 Advanced device for applica

  5. Slide 5: Key Catalysts and Outlook

    Key Catalysts and ‣ Lab demonstrator of blood potassium Outlook sensor end of 2025 ‣ Blood potassium prototype sensor mid- For personal use only Calendar years to 2027 2026 Early demo of next gen biochip applications ‣ End of 2026 begin clinical trials for blood Biochip lab Biochip prototype Biochip

  6. Slide 6: Archer's Carbon Quantum – differentiation & advantages

    QUANTUM COMPUTING Archer’s Carbon Quantum – differentiation & advantages For personal use only  Our differentiated approach is aimed at tackling current quantum technology roadblocks like manufacturability, scaling, cost, and complexity.  Our purpose is to commercialise quantum innovation in ways

  7. Slide 7: Quantum Technology: The Next Frontier

    QUANTUM COMPUTING Quantum Technology: Quantum Technology Market Growth The Next Frontier For personal use only Projections 2025-2040 Archer considers quantum technology to be the next great technological advance. ‣ Archer is the only ASX-listed quantum company. ‣ Adoption of quantum tech expected to

  8. Slide 8: BioChip

    For personal use only BioChip 02

  9. Slide 9: Biochip: High-Value Problem

    BIOCHIP ‣ Over 850M people (>10% of global High-Value Problem population) suffer from chronic kidney disease (CKD). For personal use only Archer’s biochip uses highly sensitive, high speed, low power ‣ More than US$3B total addressable market sensors to detect ions in blood. The chip will be integra

  10. Slide 10: Biochip Value Proposition (US Medicare Population)

    BIOCHIP Value Proposition (US Medicare Population) Cost per year per patient ($) For personal use only 40,000  The Problem: CKD patients with hyperkalemia drive $34,363 billions in preventable costs (>$15k per patient, >$30B total). 20,000  The Gap: No convenient, fast, low-cost potassium $15,013

  11. Slide 11: Our Solution: Archer Potassium Test

    BIOCHIP Our Solution: Archer Potassium Test The first of its kind and the most technologically advanced Built to prevent life-threatening cardiac events. For personal use only POC medical diagnostic in the world.  A technology inflection beyond decades-old lateral flow tests.  More capability and

  12. Slide 12: At-home Potassium Sensor - Roadmap

    BIOCHIP At-home Potassium Sensor - Roadmap For personal use only Phase gate development process for a diagnostic medical device regulated under ISO13485 Scale up & Development & Verification & Proof of concept Feasibility transfer to Launch Optimisation validation manufacturing 2025 • Work ramping u

  13. Slide 13: Quantum Computing and Sensing

    Quantum Computing and Sensing For personal use only 03

  14. Slide 14: Qubit Roadmap

    QUANTUM COMPUTING Qubit Roadmap For personal use only Work will be extended on devices built around nanodots of carbon. Targeting a qubit architecture demonstration in 2026. Demonstration of Electron spin state readout – Full qubit gating in Archer’s Detection of Zeeman split spin demonstration prop

  15. Slide 15: Tapping into Growing Quantum Sensor Market

    ADVANCED QUANTUM SENSING Tapping into Growing Quantum Sensor Market For personal use only ‣ Overseas foundry developing TMR sensor with Archer for industrial applications. ‣ TMR sensors have applications in AI, data centers, automotive, and IoT implementation. ‣ TMR leverages quantum phenomena to pr

  16. Slide 16: Key Partnerships

    PARTNERS Key Partnerships For personal use only Key for biochip Paragraf is one of the Partnering to integrate EPFL have been a long- We’re harnessing productization and world’s only dedicated their homolysis sensor time partner and have graphene and carbon- derisking various aspects graphene foundr

  17. Slide 17: Thank you

    Thank you For personal use only ASX Code: AXE Sydney Adelaide Website The Board of Archer authorised this Level 2, 477 Pitt St Lot Fourteen, Frome Rd www.archerx.com.au announcement to be given to ASX. Sydney NSW 2000 Adelaide SA 5000 Archer Materials Limited ABN 64 123 993 233 www.archerx.com.au

  18. Slide 18: Disclaimer

    Disclaimer The material contained in this document is a presentation of general information about the activities of Archer Materials Ltd and its related bodies For personal use only corporate (together the “Archer Group”), current as at the date of this presentation. It is provided in summary and do

Archer Materials — Shareholder Meeting (November 2025) on 6ix